ChromX Health key facts
- Developer of an intelligent breath analysis platform designed for accurate disease rapid diagnosis, early screening, disease monitoring and tracking, and chronic disease health management.
- Notable investors include ZhenFund, Fosun Venture Capital Investment, Country Garden Venture Capital, Guangzhou Science City Venture Capital, Beijing Xietong Chuangxin Holding — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch ChromX Health: the Monday email on marks, rounds and moves
ChromX Health funding rounds
No funding rounds for ChromX Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
ChromX Health investors
7 investors are on record for ChromX Health, including ZhenFund, Fosun Venture Capital Investment, Country Garden Venture Capital and Guangzhou Science City Venture Capital.
About ChromX Health
Developer of an intelligent breath analysis platform designed for accurate disease rapid diagnosis, early screening, disease monitoring and tracking, and chronic disease health management. The company offers micro-electromechanical systems technologies and artificial intelligence algorithms for multi-breath molecule full-spectrum analysis to replace the currently commonly used single-molecule breath detection, thereby enabling patients and doctors to detect and screen multiple diseases with only one breath.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2021
- Employees
- 65
- Website
- chromxhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
ChromX Health doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.